Genentech, Inc.

Lawsuit Filings

‘The Modern-Day Version of Agent Orange’: Hoffmann-La Roche, Genentech Hit with Class Action Over Antimalarial Drug

January 3, 2022 Hoffmann-La Roche and Genentech face a class action over their alleged failure to warn U.S. military service members of the “substantial and irreversible” dangers of the antimalarial drug mefloquine.

‘Wasteful’: Class Action Claims Genentech Reaped Millions by Selling Cancer, Asthma Drugs in Excessive Dosage Amounts

September 25, 2020 A class action claims Genentech has sold medications in single-use vials that contain more medicine than is appropriate for most patients, causing excessive waste.